Rezultati

eNauka >  Results >  Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer
Title: Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer
Authors: Van, Cutsem Eric; Hidalgo, Manuel; Canon, Jean-Luc; Macarulla, Teresa; Bazin, Igor; Poddubskaya, Elena; Manojlović, Nebojša S.  ; Radenkovic, Dejan V; Verslype, Chris; Eric, Raymond;
Issue Date: 2018
Publication: INTERNATIONAL JOURNAL OF CANCER
ISSN: 0020-7136 e1097-0215 International Journal of Cancer Search Idenfier
Publisher: Wiley
Type: Article
Collation: vol. 143 br. 8 str. 2053-2064
DOI: 10.1002/ijc.31603
WoS-ID: 000443942800022
Scopus-ID: 2-s2.0-85051645817
URI: https://enauka.gov.rs/handle/123456789/812938
URL: https://ezproxy.nb.rs:2062/doi/pdf/10.1002/ijc.31603
Project: Merck KGaA, Darmstadt, Germany [NCT01016483]
EMD Serono, Inc. [NCT01016483]
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21aM21a

83
SCOPUSTM
51
OpenCitations
85
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.